Published by ChinaMNC · Qiaojia

Yunnan's 15th Five-Year Plan for Traditional Chinese Medicine Materials: What Foreign Founders Should Know

A practical briefing for foreign founders on Yunnan Province's 15th Five-Year Plan for the traditional Chinese medicine materials industry, covering variety priorities, GAP bases, under-forest cultivation, processing, market stabilization, food-medicine homology, and AI application.

Yunnan's Plan for Traditional Chinese Medicine Materials: A Founder's Briefing

Yunnan Province has published a plan for the development of its traditional Chinese medicine (TCM) materials industry during the 15th Five-Year Plan period. For foreign founders building businesses in China around herbal materials, health products, or related supply chains, the plan signals where provincial priorities and support are likely to concentrate. This article summarizes the published content in practical terms.

Headline Targets: Less Area, More Value

By 2030, the plan expects the area devoted to TCM material cultivation to fall by 1.608 million mu, while the comprehensive output value target rises by 50 billion yuan. The stated logic is to exchange a reduction in planted area for gains in quality, processing, branding, and efficiency. Foreign founders should read this as a quality-over-quantity signal rather than a contraction of the sector.

Which Varieties Are Prioritized

Building on the 156 varieties listed in the 2024 edition of the Yunnan Catalogue of Authentic Medicinal Materials, the plan sets out three tiers of focus:

• Authentic advantage varieties, led by the "Top Ten Yunnan Medicines": Panax notoginseng, Yunnan Paris polyphylla, Erigeron breviscapus, Dendrobium officinale, Amomum villosum, Gastrodia elata, Yunnan Poria, Yunnan Angelica sinensis, Yunnan Aucklandia lappa, and Yunnan Gentiana.
• Health-oriented specialty varieties, centered on the "Top Ten Health Resources": Yunnan Polygonatum kingianum, safflower, Bletilla striata, purple-skin Dendrobium, Phyllanthus emblica (Yunnan olive), Coix seed, Terminalia chebula, Amomum tsaoko, ginger, and star anise.
• Potential cultivation varieties, represented by the "Six Southern Medicines": Amomum villosum, dragon's blood, Cibotium barometz, agarwood, Orthosiphon aristatus, and Dai Bai Jie.

For founders, these lists are a useful guide to where provincial attention, standards, and supply-chain development are likely to be directed.

Standardized Cultivation: GAP Bases

The plan aims to build 200 TCM material GAP (Good Agricultural Practice) bases. Priority is given to full GAP coverage for Wenshan Panax notoginseng, with orderly progress on GAP bases for under-forest varieties such as Poria, Amomum villosum, Amomum tsaoko, and Phellodendron. The province also intends to develop a number of national-level high-standard TCM material raw material production bases. Foreign founders sourcing raw materials may find GAP-linked supply increasingly relevant to quality assurance and buyer requirements.

Under-Forest Cultivation

Focusing on authentic materials such as Panax notoginseng, Gastrodia elata, Poria, Amomum villosum, Polygonatum, and Phellodendron, the plan promotes under-forest cultivation and breeding of TCM materials, with ecological and under-forest planting bases to expand to more than 6 million mu. Founders exploring cultivation-linked partnerships should note this emphasis on forest-based production models.

Origin Processing and Higher-Value Products

The plan supports establishing processing lines at production origins in authentic material areas and high-standard raw material bases. It promotes linking GAP base materials with fresh cutting and upgrading products from primary raw materials to semi-industrialized input materials. It also supports enterprises in building modern deep-processing lines, developing high-value-added products, and forming a series of Yunnan medicine big-health products. Research and industrialization of daily chemical and beauty products and functional health products are explicitly encouraged. This suggests openings for founders in processing, formulation, and branded health products.

Market Stabilization and Risk Warning

For bulk varieties and scarce varieties vulnerable to market swings, such as Panax notoginseng, Angelica sinensis, and Paris polyphylla, the plan calls for adjustment through market-based methods to smooth fluctuations. It also calls for an information monitoring and early-warning system to guard against industry risks such as blind expansion of planting and falling prices hurting farmers. Founders dependent on raw material pricing should factor this monitoring framework into supply planning.

Food-Medicine Homology Development

The plan calls for standards for food-medicine homology raw materials, including quality standards and production and processing specifications. It targets cross-border registration and launch of 5 to 10 new products and plans a "Yunnan Medicine Food-Medicine Homology Culture Festival." Founders in the functional food and cross-border product space may see opportunities tied to these standards and registration goals.

The "Yunnan Medicine Brain" AI Initiative

The plan includes an artificial intelligence innovation application project called "Yunnan Medicine Brain," intended to build an intelligent application system covering the full life cycle of TCM materials. It focuses on key areas of TCM materials and aims to form multi-level, multi-scenario intelligent solutions. Founders in agritech, traceability, or data services may find relevant angles.

Practical Takeaways for Foreign Founders

• Align product and sourcing plans with the prioritized variety lists, especially the Top Ten Yunnan Medicines and Top Ten Health Resources.
• Track GAP base development, particularly for Wenshan Panax notoginseng and under-forest varieties, as a quality signal.
• Consider origin processing and deep-processing opportunities in authentic material areas.
• Watch food-medicine homology standards and the planned cross-border registrations if you operate in functional foods.
• Build raw material pricing and supply plans with awareness of the province's market monitoring and early-warning direction.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.